Effect of an Acute Viral Infection by a Silent Virus on the Humoral Immune Responses

  • Noah Isakov
  • Michael Feldman
  • Shraga Segal
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 149)


Investigations on the effect of virus infections on the host’s immune system started almost twenty years ago when Peterson et al. demonstrated that Gross virus-infected mice are impaired in their ability to respond in antibody production to the T2 bacteriophage (1). Similar findings were reported in animals infected with other oncogenic viruses, such as Moloney, Friend or Rauscher leukemia viruses (2–4). Viruses which do not cause leukemia but infect lymphoid tissue were also found to modulate immune responses. Thus Aleutian mink disease virus (5), lymphocytic choriomeningitis virus (6) and M-P virus (7) were found to degress the host humoral responses to sheep erythrocytes (SRBC), while Venezuelan equine encephalitis virus (8) and lactic dehydrogenase virus (LDV; 9–14) were found to enhance antibody responses to human gamma globulin (HGG) or SRBC.


Infected Mouse Venezuelan Equine Encephalitis Virus Lymphocytic Choriomeningitis Virus Acute Viral Infection Aleutian Mink Disease Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R.D.A. Peterson, R. Hendrickson, and R.A. Good. Proc. Soc. Exp. Biol. Med. 114:517 (1963).PubMedGoogle Scholar
  2. 2.
    N.E. Cremer, D.O.N. Taylor, and S.J. Hagens. J. Immunol. 96:495 (1966).PubMedGoogle Scholar
  3. 3.
    Ceglowski, W.S., and H. Friedman. J. Natl. Cancer Inst. 40:983 (1968).PubMedGoogle Scholar
  4. 4.
    S.J. Millian, and M. Schaeffer. Cancer 21:989 (1968).PubMedCrossRefGoogle Scholar
  5. 5.
    D.D. Porter, F.J. Dixon, and A.E. Larsen. J. Exp. Med. 121:889 (1965).PubMedCrossRefGoogle Scholar
  6. 6.
    C.A. Mims, and S. Wainwright. J. Immunol. 101:717 (1968).PubMedGoogle Scholar
  7. 7.
    M. Padnos, N. Molomut, and R. Hofer. Fed. Proc. 28:430 (1969).Google Scholar
  8. 8.
    R.J. Howard, C.P. Craig, G.S. Trevino, S.F. Dougherty, and S.E. Mergenhagen. J. Immunol. 103:699 (1969).PubMedGoogle Scholar
  9. 9.
    A.L. Notkins, S.E. Mergenhagen, A.A. Rizzo, C. Scheele, and T.A. Waldmann. J. Exp. Med. 123:347 (1966)PubMedCrossRefGoogle Scholar
  10. 10.
    M.B.A. Oldstone, A. Tishon, and J.M. Chiller. J. Immunol.112:370 (1974).PubMedGoogle Scholar
  11. 11.
    V. Riley, W. Braun, M. Ishizuka, and D. Spackman. Proc. Natl. Acad. Sci. USA 73:1707 (1976).PubMedCrossRefGoogle Scholar
  12. 12.
    M.C. Michaelides, and E.S. Simms. Immunology 32:981 (1977).PubMedGoogle Scholar
  13. 13.
    N. Isakov, M. Feldman, and S. Segal. Israel J. Med. Sci. 16:810 (1980).Google Scholar
  14. 14.
    M.C. Michaelides, and E.S. Simms. Cell. Immunol. 50:253 (1980).PubMedCrossRefGoogle Scholar
  15. 15.
    S.E. Mergenhagen, A.L. Notkins, and S.F. Dougherty. J. Immunol. 99:576 (1967).PubMedGoogle Scholar
  16. 16.
    N.. Jerne, and A.A. Nordin. Science 140:405 (1963).CrossRefGoogle Scholar
  17. 17.
    N. Isakov, S. Segal, N. Hollander, and M. Feldman. Int. J. Cancer 22:465 (1978).PubMedCrossRefGoogle Scholar
  18. 18.
    V. Riley, in: “Methods in Cancer Research,” 4:493, H. Busch, ed., Academic Press, New York (1968).Google Scholar
  19. 19.
    V. Riley, and D. Spackman, in: “Fogarty International Center Proc. No. 28”, U.S. Government Printing Office, Washington, DC (1976).Google Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • Noah Isakov
    • 1
  • Michael Feldman
    • 1
  • Shraga Segal
    • 1
  1. 1.Department of Cell BiologyThe Weizmann Institute of ScienceRehovotIsrael

Personalised recommendations